Top Markets
Coin of the day
Paragon 28, Inc. Paragon 28, Inc.

Paragon 28, Inc.

FNA
Rang in Aktien #9071
Paragon 28, Inc. is a medical device company specializing in the development,... Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.
Aktienkurs
$13.09
Zuletzt synchronisiert: 2025-04-17
Marktkapitalisierung
$1.10B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Paragon 28, Inc. (FNA)

Kategorie

Anzahl der ausstehenden Aktien von Paragon 28, Inc. (FNA)
Anzahl der ausstehenden Aktien zum December 2024: 83.31M
Laut den neuesten Finanzberichten und dem Aktienkurs von Paragon 28, Inc. beträgt die aktuelle Anzahl der ausstehenden Aktien 83.31M. Am Ende von December 2023 hatte das Unternehmen 82.09M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Paragon 28, Inc. (FNA) von 2019 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 83.31M 0.00%
2024 83.31M 1.49%
2023 82.09M 6.93%
2022 76.77M 0.42%
2021 76.45M 0.09%
2020 76.37M 80.91%
2019 42.22M 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
1.74B 1,992.21%
US
383.50M 360.32%
US
1.28B 1,438.93%
IE
1.48B 1,673.59%
US
- -
DE